PMID: 8591697Aug 1, 1995Paper

Elevated ratio of summed serum proinsulin to insulin response after oral glucose load in type 2 diabetes decreases following sulfonylurea treatment

Diabetes Research and Clinical Practice
S KumakuraT Saito

Abstract

We showed previously that the disproportionate elevation of serum proinsulin at fasting and after glucose ingestion in Type 2 diabetes is reduced to nearly normal after improvement of glycemic control by diet therapy. In this study, we investigated the effect of sulfonylurea (SU) treatment on serum proinsulin levels and proinsulin/insulin ratio (PI/I) during oral glucose tolerance test in patients with Type 2 diabetes. Thirteen diabetic patients (age 56 +/- 9 years, body mass index 22.4 +/- 1.9 kg/m2, mean +/- SD) were examined by 75 g oral glucose tolerance test (OGTT) before and after glycemic control by SU therapy. Mean interval of two OGTTs was 126 days. Serum proinsulin was measured by the radioimmunoassay using a human proinsulin-specific antiserum. When glycemic control improved after SU therapy (mean fasting plasma glucose 11.5 and 6.0 mmol/l, before and after SU treatment), fasting insulin, proinsulin and PI/I ratio did not change significantly. Insulin response during OGTT markedly increased after SU therapy. Summed value of insulin (sigma I) increased from 634 to 1064 pmol/l after SU (P < 0.01), whereas summed proinsulin (sigma PI) did not change significantly (146 and 159 pmol/l), resulting in a significant decrease...Continue Reading

References

Dec 1, 1977·The American Journal of Medicine·M E MakoA H Rubenstein
Aug 1, 1991·Diabetes·J L LeahyG C Weir
May 1, 1990·The Journal of Clinical Endocrinology and Metabolism·M F SaadD Porte
Nov 1, 1986·The Journal of Clinical Endocrinology and Metabolism·V A KoivistoR Pelkonen
May 1, 1973·The Journal of Clinical Investigation·A I Katz, A H Rubenstein
Apr 1, 1972·The Journal of Clinical Investigation·A H RubensteinD F Steiner
Jun 1, 1984·The Journal of Clinical Endocrinology and Metabolism·R M BergenstalK Steiner
Apr 1, 1994·Diabetic Medicine : a Journal of the British Diabetic Association·M J DaviesI P Gray

❮ Previous
Next ❯

Citations

Apr 20, 2001·Diabetes Research and Clinical Practice·P S van der Wal, R J Heine
May 1, 2007·Diabetes Research and Clinical Practice·Yoshifumi SaishoTakao Saruta

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.